Alirocumab for the treatment of hypercholesterolemia.

about

The ODYSSEY DM-DYSLIPIDEMIA trial: confirming the benefits of alirocumab in diabetic mixed dyslipidemia.A safety evaluation of evolocumab.

P2860

Q47130329-AE3C0916-3648-4DFB-A453-96AF473FE090 Q47681415-C34FCF86-1DA1-469A-8DCD-55B967CE6A93

P2860

Alirocumab for the treatment of hypercholesterolemia.

Item

http://www.wikidata.org/entity/Q38917894

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Alirocumab for the treatment of hypercholesterolemia.

@en

type

Item

label

Alirocumab for the treatment of hypercholesterolemia.

@en

prefLabel

Alirocumab for the treatment of hypercholesterolemia.

@en

P1476

Alirocumab for the treatment of hypercholesterolemia.

@en

P2093

Brian Tomlinson

http://www.w3.org/2001/XMLSchema#string

Miao Hu

http://www.w3.org/2001/XMLSchema#string

Paul Chan

http://www.w3.org/2001/XMLSchema#string

Yuzhen Zhang

http://www.w3.org/2001/XMLSchema#string

Zhong-Min Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation

The PCSK9 decade

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

A Highly Durable RNAi Therapeutic Inhibitor of PCSK9.

Effect of a monoclonal antibody to PCSK9 on LDL cholesterol.

Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.

P304

633-643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14712598.2017.1305354

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28277798

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

Alirocumab for the treatment of hypercholesterolemia.

about

P2860

P2860

Alirocumab for the treatment of hypercholesterolemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921